It’s a very rewarding trading day for investors in Gemphire Therapeutics (NASDAQ:GEMP) with shares up over 90%, making the stock Wall Street’s bull …
Monday turned out to be a nightmare for Gemphire Therapeutics Inc (NASDAQ:GEMP) investors, after the biopharmaceutical company reported disappointing LDL data from its Phase 2b …
